NCT04084938.
Study name | Artery embolization vs operation of benign prostate hyperplasia (NORTAPE) |
Methods |
Study design: parallel randomized controlled trial (open label) Setting/country: single center/Norway |
Participants | Inclusion criteria: LUTS from BPH with moderate and severe IPSS score (IPSS > 8) and QoL ≥ 3; refractory to medical treatment for ≥ 6 months or the patient is unwilling to accept medical treatment; BPH using permanent or intermittent catheterization; prostate volume > 50 mL; signed informed consent |
Interventions |
Group A: PAE Group B: prostate operation through a catheter into the penis or through an incision in lower abdomen |
Outcomes |
Primary outcome
Secondary outcomes
|
Starting date | September 2019 |
Contact information | fagreda.germanstrias@gencat.cat |
Notes | Sponsor: Oslo University Hospital |